Primary cardiac lipoma: a clinicopathological analysis Authors: Shuai Luo, Anying Long, Xiaoxue Tian, Ting Xu, Qiyao Ge, Jinjing Wang Published: 2025 ABSTRACT ObjectiveThis study aims to examine the clinicopathological features of three rare cases of cardiac lipoma.MethodsThis retrospective case analysis utilized a search of the institutional pathology database. Predefined inclusion criteria (pathologically confirmed primary cardiac lipoma with complete clinicopathological data) and exclusion criteria (non-neoplastic fatty lesions, other cardiac tumors, or incomplete data) were applied. Three eligible cases of primary cardiac lipoma were identified. Clinical presentations, imaging findings, pathological diagnoses, treatments, and outcomes were summarized alongside a literature review.ResultsThe three patients included two males and one female, aged 44 to 75 years (mean, 57 years). Tumor diameters ranged from 2 to 4.5 cm (mean, 3 cm), all located in the right atrium. Cardiac ultrasound consistently showed well-defined, isoechoic masses. Gross examination revealed soft, yellowish, fatty nodules with a surrounding capsule. Pathological diagnosis confirmed lipoma. During follow-up (2 to 6 years), no recurrence was noted.ConclusionsPrimary cardiac lipoma typically affects middle-aged and elderly males, exhibits slow growth, and carries a favorable prognosis with rare recurrence following complete excision. This study, presenting three pathologically confirmed cases with long-term follow-up, alongside a literature review, aims to improve understanding of this rare condition and reduce both misdiagnosis and overdiagnosis. Background Primary cardiac tumors are exceedingly rare, with autopsy incidences ranging from 0.0017% to 0.19% [1]. The advent of imaging technologies such as echocardiography, cardiac computed tomography (CT), and magnetic resonance imaging (MRI) has significantly improved the ability to detect these tumors in living patients. Primary cardiac lipomas present a diagnostic challenge due to their subtle onset, varied imaging characteristics, and nonspecific symptoms. They are often misidentified as other benign or malignant cardiac tumors, such as myxomas, hemangiomas, and liposarcomas, and at times, as thrombi or myxomas, which can lead to inappropriate management. Therefore, mastering key imaging and histological differentiators is critical for accurate diagnosis. This study reports three cases of primary cardiac lipoma and, through a literature review, examines their imaging differentiation, pathological diagnostic features, and clinical management strategies. The goal is to enhance recognition among clinicians and pathologists, reducing the risk of misdiagnosis and unnecessary interventions. Case demonstration Case 1 A 44-year-old female presented with a 5-day history of “palpitations and fatigue.” The symptoms were more pronounced in the early morning, without chest pain or shortness of breath. Cardiac ultrasound revealed a well-defined isoechoic mass in the right atrium, suggestive of a myxoma, along with mild mitral and tricuspid valve regurgitation. Given the patient’s significant symptoms and the identified intracardiac mass, resection of the right atrial tumor was performed under cardiopulmonary bypass to alleviate symptoms and confirm the pathological diagnosis. Intraoperative findings revealed the tumor located at the orifice of the inferior vena cava in the right atrium, consistent with intracavitary cardiac lipoma. The tumor was completely excised, followed by local endocardial repair and closure of the patent foramen ovale, with no need for valve replacement or reconstruction. Gross examination revealed a single, well-encapsulated, yellowish, soft fatty tissue specimen measuring approximately 2.0 × 1.5 × 1.0 cm, with a greasy, yellowish cut surface. Case 2 A 51-year-old male was referred for evaluation after an incidental finding of a cardiac mass during a physical examination. He reported no palpitations, chest tightness, or shortness of breath. Chest CT revealed a well-defined fat-density lesion (CT value approximately − 100 to −120 HU) in the right atrial region. Cardiac MRI confirmed a fat-signal mass near the interatrial septum on the posterior wall of the right atrium. Echocardiography demonstrated a homogeneous, well-defined isoechoic mass (approximately 25 × 14 mm) near the interatrial septum at the roof of the right atrium. Despite being asymptomatic, the presence of the right atrial mass prompted surgical intervention to prevent potential complications, such as embolism or arrhythmia, and to rule out other tumors, including liposarcoma. The patient underwent tumor resection under cardiopulmonary bypass. Intraoperative findings revealed a well-defined, soft mass on the lateral wall of the right atrium (intracavitary type), clearly separate from the tricuspid valve apparatus. The tumor was completely excised without the need for valve repair. Gross examination showed a single, encapsulated, yellowish-to-yellowish-white tissue mass measuring approximately 2.5 × 2.0 × 1.6 cm, with a soft, greasy, yellowish cut surface. Case 3 A 75-year-old male presented with a 6-month history of “chest tightness and exertional shortness of breath,” which had worsened in the last 5 days. He also reported a recent weight loss of approximately 3 kg. Echocardiography (Fig. 1) revealed a solid mass in the right atrium, accompanied by interventricular septal thickening, a dilated aortic sinus and ascending aorta, scattered aortic valve calcification with mild-to-moderate regurgitation, and mild tricuspid regurgitation. Coronary CT angiography (Fig. 2) identified a fat-density lesion or lipoma at the inferior border of the right atrium. The 3D coronary CT(Fig. 3) reconstruction shows that the middle and distal segments of the right coronary artery partially pass through or bypass a lipoma or fat accumulation mass at the lower margin of the right atrium. Cardiac MRI with contrast (Fig. 4) demonstrated a nodular lesion on the right atrial side of the interatrial septum, characterized by short T1 and long T2 signals, measuring approximately 44 × 32 × 32 mm, with signal loss on fat-suppressed T1-weighted sequences and no enhancement, consistent with a fatty tumor. Given the significant exertional symptoms and the large tumor size (4.5 cm), which substantially impacted cardiac hemodynamics, surgical resection under cardiopulmonary bypass was indicated. Intraoperative findings revealed the tumor in the subendocardial (intramural) region between the inferior vena cava and the coronary sinus orifice (intramural type). Complete tumor excision with local endocardial repair was performed, with no involvement of the tricuspid valve or coronary sinus ostium, and no valve repair was required. Gross examination (Fig. 5) showed a yellowish, partially encapsulated tissue mass measuring 4.5 × 3.0 × 2.0 cm, with a soft, greasy cut surface. Fig. 1Fig. 1: Conventional echocardiography reveals a 41 × 37 mm hypoechoic solid mass (A, red arrow) in the right atrium, slightly displaced toward the right. Left ventricular echogenic contrast imaging shows a 37 × 28 mm echogenic mass (B, red arrow) with minimal low enhancement, well-defined margins, and a 23 mm base connected to the right atrial wall Fig. 1: Conventional echocardiography reveals a 41 × 37 mm hypoechoic solid mass (A, red arrow) in the right atrium, slightly displaced toward the right. Left ventricular echogenic contrast imaging shows a 37 × 28 mm echogenic mass (B, red arrow) with minimal low enhancement, well-defined margins, and a 23 mm base connected to the right atrial wall Fig. 2The CT scan reveals a fat accumulation mass at the lower margin of the right atrium (red arrow, A: Non-contrast chest CT soft tissue sequence; B: Non-contrast chest CT lung tissue sequence; C: Non-contrast coronary CT; D: Contrast-enhanced coronary CT.) The CT scan reveals a fat accumulation mass at the lower margin of the right atrium (red arrow, A: Non-contrast chest CT soft tissue sequence; B: Non-contrast chest CT lung tissue sequence; C: Non-contrast coronary CT; D: Contrast-enhanced coronary CT.) Fig. 3The 3D coronary CT reconstruction shows that the middle and distal segments of the right coronary artery partially pass through or bypass a lipoma or fat accumulation mass at the lower margin of the right atrium (red arrow, A: Posterior view, B: Lateral view.) The 3D coronary CT reconstruction shows that the middle and distal segments of the right coronary artery partially pass through or bypass a lipoma or fat accumulation mass at the lower margin of the right atrium (red arrow, A: Posterior view, B: Lateral view.) Fig. 4MRI of the heart: A nodular short T1 (red arrow, A) and long T2 (red arrow, B) signal shadow on the right atrial surface of the atrial septum, measuring approximately 44 × 32 × 32 mm, with absent signal on T1 fat-saturated sequence and no enhancement, suggesting a lipomatous tumor MRI of the heart: A nodular short T1 (red arrow, A) and long T2 (red arrow, B) signal shadow on the right atrial surface of the atrial septum, measuring approximately 44 × 32 × 32 mm, with absent signal on T1 fat-saturated sequence and no enhancement, suggesting a lipomatous tumor Fig. 5Gross examination of the tumor from Case 3 shows a partially encapsulated, soft, yellowish-tan mass with a greasy cut surface Gross examination of the tumor from Case 3 shows a partially encapsulated, soft, yellowish-tan mass with a greasy cut surface Microscopic examination of all three cases demonstrated similar features. The tumors were well-circumscribed with a fibrous capsule (Fig. 6). Mature adipocytes were arranged in lobules separated by fibrous septa, with a minor vascular component (Fig. 7). The adipocytes were uniform in size, with lipid-filled cytoplasm, small nuclei, no atypia, and no pathological mitotic figures (Fig. 8). Fig. 6Microscopic examination reveals a well-defined mass with a complete fibrous capsule. H&E × 4.4 Microscopic examination reveals a well-defined mass with a complete fibrous capsule. H&E × 4.4 Fig. 7Adipocytes are interspersed with small blood vessels. H&E × 17.8 Adipocytes are interspersed with small blood vessels. H&E × 17.8 Fig. 8Adipocytes are uniform in size, with cytoplasm filled with lipid droplets and small nuclei, showing no atypia. H&E × 200 Adipocytes are uniform in size, with cytoplasm filled with lipid droplets and small nuclei, showing no atypia. H&E × 200 Histomorphological analysis confirmed the diagnosis of right atrial lipoma in all cases. Following diagnosis, the patients were monitored for 6, 4, and 2 years, respectively, through outpatient visits and periodic echocardiography. All patients maintained normal cardiac function with no recurrence or related complications. Discussion Cardiac tumors can be classified as primary or secondary, with primary tumors being significantly rarer than secondary ones [2]. Among primary cardiac tumors, cardiac lipomas are exceptionally rare, accounting for only 0.5–3% of resected cases [3–6]. These tumors include solitary lipomas, infiltrating lipomas, and specialized forms such as lipomatous hamartomas of the atrioventricular valves and lipomatous hypertrophy of the interatrial septum. Cardiac lipomas can develop in any area of the heart, though they are most frequently reported in the right atrium, pericardium, and epicardial surface, where they may grow to a substantial size [7–9]. They can also arise from cardiac valves and the interventricular septum, with valvular lipomas often referred to as “fibrolipomas” [10]. Although the sites of predilection vary across studies, no definitive consensus on a common location has been established. Despite being benign, cardiac lipomas can cause significant complications such as angina, arrhythmias, heart failure, and even sudden death, especially when they attain large sizes. Surgical resection typically offers a curative outcome, highlighting the importance of early diagnosis and intervention. Advancements in multimodal imaging have greatly improved the diagnostic and differentiating capabilities for cardiac lipomas. Li Zhao et al. [11] reported a giant right atrial lipoma, with MRI revealing high signal intensity on both T1- and T2-weighted images, along with significant signal loss on fat-suppressed sequences. Shu et al. [12] emphasized that lipomas typically show homogeneous high signals on MRI, signal loss after fat suppression, and no substantial enhancement, with symptoms correlating closely to tumor size and location. In our series, all cases were located in the right atrium, with a mean maximum diameter of approximately 3–4 cm, consistent with the commonly observed range of 2–5 cm [11, 12, 16]. Clinically, one case was detected incidentally during a physical examination, while two cases presented with symptoms attributed to mass effect or hemodynamic compromise, reflecting the clinical spectrum from asymptomatic to symptomatic presentations, depending on compression or hemodynamic impact. Additionally, cardiac magnetic resonance parametric mapping, as proposed by Bonnes et al. [13], offers refined quantitative tissue characterization, which can help differentiate lipomas from liposarcomas and myxomas. From a histological perspective, cardiac fatty lesions primarily include fatty hyperplasia and lipoma. Fatty hyperplasia, commonly found in the interatrial septum, is characterized by non-neoplastic excessive proliferation of adipose tissue and is usually unencapsulated. In contrast, lipomas are true benign tumors composed of mature adipocytes, typically encapsulated and well-demarcated from surrounding tissues. Cardiac lipomas are classified into three types based on their anatomical location: epicardial, intramural, and intracavitary. The intracavitary type is the most common and can cause hemodynamic obstruction or valve compression symptoms [14]. All three cases in this series were intracavitary type, located in the right atrium, with no malignant features. Clinically, cardiac lipomas can affect individuals of any age or gender. Symptoms primarily depend on the tumor’s location, size, and its effect on surrounding cardiac structures. Small tumors may be asymptomatic, while larger ones can induce angina or impair cardiac pump function. In this series, Cases 1 and 3, with larger tumor volumes, presented with significant cardiovascular symptoms (e.g., palpitations, chest tightness, dyspnea), suggesting a hemodynamic impact. In contrast, Case 1, with a smaller tumor located in the posterior wall of the right atrium, was asymptomatic and discovered incidentally. This variability in clinical presentation highlights the importance of tumor location and size as critical factors in symptom development, consistent with prior literature. Arrhythmias associated with cardiac lipomas may result from compression, mechanical irritation, or invasion of the conduction system. Common arrhythmic manifestations include atrial arrhythmias, ventricular arrhythmias, and conduction blocks. In this series, Case 1 presented with “palpitations,” likely attributed to atrial arrhythmias due to the right atrial mass. Case 1, with a tumor that did not involve conduction pathways, showed no arrhythmic manifestations, further supporting the relationship between arrhythmia and tumor location/size. Regarding imaging, echocardiography is the primary screening tool for cardiac lipoma, providing a non-invasive and convenient method to assess tumor location, size, borders, and blood flow. It typically shows a well-defined, homogeneous, hyperechoic mass, similar to the echogenicity of adipose tissue [15]. CT scanning offers additional details on the lesion’s density and extent, often revealing a well-circumscribed, homogeneous solitary mass [16], with attenuation values typically below − 50 Hounsfield Units [17]– [18]. MRI is the most specific modality for differential diagnosis, accurately identifying the fatty component by demonstrating homogeneous high signal on T1- and T2-weighted images, complete signal loss on fat-suppression sequences, and no significant post-contrast enhancement. Thus, MRI plays a pivotal role in diagnosing cardiac lipoma and distinguishing it from other cardiac tumors. Pathologically, the gross appearance is typically a yellowish-brown, soft, encapsulated mass. Microscopically, mature adipocytes are arranged in lobules, exhibiting uniform size, no atypia, and no pathological mitotic figures. Lipoma cells often express S-100 protein, and lipid droplet-associated proteins such as adipophilin and perilipin demonstrate high specificity. Special stains, such as Oil Red O or Sudan III, can be employed when necessary for further characterization. Given the extreme rarity of cardiac lipoma, it is essential to consider the following entities in the pathological differential diagnosis: Lipomatous Hypertrophy of the Interatrial Septum: This is a non-neoplastic, tumor-like lesion characterized by diffuse thickening (> 2 cm) of the interatrial septum (typically sparing the fossa ovalis) due to the proliferation of mature adipocytes and brown fat cells. The primary distinguishing feature from an encapsulated, expansile solitary lipoma is the absence of a capsule and the presence of hypertrophied cardiomyocytes within the adipose tissue. Its location is diagnostically significant, as it is almost exclusively confined to the interatrial septum.Well-Differentiated Liposarcoma (WDLS)/Atypical Lipomatous Tumor (ALT): WDLS/ALT represents the most critical differential diagnosis, as it significantly influences treatment and prognosis. Although both WDLS/ALT and lipomas are composed predominantly of mature adipose tissue, WDLS/ALT exhibits cytological atypia, including variation in adipocyte and stromal cell size, hyperchromatic enlarged nuclei, and multinucleated stromal cells within fibrous septa. Molecular pathology is essential for definitive differentiation, as over 95% of WDLS/ALT cases harbor MDM2 gene amplification, detectable by immunohistochemistry (MDM2 and CDK4 nuclear positivity) and fluorescence in situ hybridization (FISH). Lipomas lack this genetic alteration.Hibernoma: A rare benign tumor of brown fat, hibernoma has distinct histological features compared to a typical lipoma. It is composed of a mixture of brown adipocytes with granular eosinophilic cytoplasm, ordinary white adipocytes, and transitional cells. The unique polymorphous cell population aids in distinguishing it from lipomas on light microscopy. Furthermore, immunohistochemistry is essential for diagnosis, as hibernoma cells often show nuclear expression of Uncoupling Protein 1 (UCP1), a specific marker for brown fat cells, which is absent in lipomas [19].Cardiac Angiolipoma: A subtype of lipoma characterized by a prominent network of branching small blood vessels, sometimes containing microthrombi. In contrast, classic lipomas have sparse vascular components and lack such a vascular network. This subtype is also rare in the heart but must be considered when vascular components are prominent.Pericardial Fat Pad: This is a physiological accumulation of extrapericardial fat, not a true neoplasm. Unlike lipomas, it lacks a capsule, does not produce a mass effect, and does not compress cardiac structures. Microscopically, it consists solely of mature adipose tissue. Differentiation from a pericardial lipoma is primarily based on imaging and gross examination, which reveals a non-encapsulated, non-mass-like nature.Cardiac Myxoma: The most common primary cardiac tumor, cardiac myxomas have distinct histological features compared to lipomas. They are characterized by an abundant myxoid background, with scattered stellate or spindle-shaped cells, often arranged perivascularly, frequent hemorrhage, and hemosiderin deposition. Myxomas do not contain mature adipocytes. Immunohistochemically, myxoma cells typically express Calretinin and CD34, while lipoma cells express S-100.Metastatic Tumors: Metastases, such as liposarcoma, renal cell carcinoma, hepatocellular carcinoma, or malignant melanoma, may resemble lipomas due to their lipid content or clear cytoplasm. Differentiation requires a thorough correlation with the clinical history (e.g., the presence of a primary malignancy) and immunohistochemical markers (e.g., RCC, HepPar-1, HMB45), which are not present in lipomas. Lipomatous Hypertrophy of the Interatrial Septum: This is a non-neoplastic, tumor-like lesion characterized by diffuse thickening (> 2 cm) of the interatrial septum (typically sparing the fossa ovalis) due to the proliferation of mature adipocytes and brown fat cells. The primary distinguishing feature from an encapsulated, expansile solitary lipoma is the absence of a capsule and the presence of hypertrophied cardiomyocytes within the adipose tissue. Its location is diagnostically significant, as it is almost exclusively confined to the interatrial septum. Lipomatous Hypertrophy of the Interatrial Septum: This is a non-neoplastic, tumor-like lesion characterized by diffuse thickening (> 2 cm) of the interatrial septum (typically sparing the fossa ovalis) due to the proliferation of mature adipocytes and brown fat cells. The primary distinguishing feature from an encapsulated, expansile solitary lipoma is the absence of a capsule and the presence of hypertrophied cardiomyocytes within the adipose tissue. Its location is diagnostically significant, as it is almost exclusively confined to the interatrial septum. Well-Differentiated Liposarcoma (WDLS)/Atypical Lipomatous Tumor (ALT): WDLS/ALT represents the most critical differential diagnosis, as it significantly influences treatment and prognosis. Although both WDLS/ALT and lipomas are composed predominantly of mature adipose tissue, WDLS/ALT exhibits cytological atypia, including variation in adipocyte and stromal cell size, hyperchromatic enlarged nuclei, and multinucleated stromal cells within fibrous septa. Molecular pathology is essential for definitive differentiation, as over 95% of WDLS/ALT cases harbor MDM2 gene amplification, detectable by immunohistochemistry (MDM2 and CDK4 nuclear positivity) and fluorescence in situ hybridization (FISH). Lipomas lack this genetic alteration. Well-Differentiated Liposarcoma (WDLS)/Atypical Lipomatous Tumor (ALT): WDLS/ALT represents the most critical differential diagnosis, as it significantly influences treatment and prognosis. Although both WDLS/ALT and lipomas are composed predominantly of mature adipose tissue, WDLS/ALT exhibits cytological atypia, including variation in adipocyte and stromal cell size, hyperchromatic enlarged nuclei, and multinucleated stromal cells within fibrous septa. Molecular pathology is essential for definitive differentiation, as over 95% of WDLS/ALT cases harbor MDM2 gene amplification, detectable by immunohistochemistry (MDM2 and CDK4 nuclear positivity) and fluorescence in situ hybridization (FISH). Lipomas lack this genetic alteration. Hibernoma: A rare benign tumor of brown fat, hibernoma has distinct histological features compared to a typical lipoma. It is composed of a mixture of brown adipocytes with granular eosinophilic cytoplasm, ordinary white adipocytes, and transitional cells. The unique polymorphous cell population aids in distinguishing it from lipomas on light microscopy. Furthermore, immunohistochemistry is essential for diagnosis, as hibernoma cells often show nuclear expression of Uncoupling Protein 1 (UCP1), a specific marker for brown fat cells, which is absent in lipomas [19]. Hibernoma: A rare benign tumor of brown fat, hibernoma has distinct histological features compared to a typical lipoma. It is composed of a mixture of brown adipocytes with granular eosinophilic cytoplasm, ordinary white adipocytes, and transitional cells. The unique polymorphous cell population aids in distinguishing it from lipomas on light microscopy. Furthermore, immunohistochemistry is essential for diagnosis, as hibernoma cells often show nuclear expression of Uncoupling Protein 1 (UCP1), a specific marker for brown fat cells, which is absent in lipomas [19]. Cardiac Angiolipoma: A subtype of lipoma characterized by a prominent network of branching small blood vessels, sometimes containing microthrombi. In contrast, classic lipomas have sparse vascular components and lack such a vascular network. This subtype is also rare in the heart but must be considered when vascular components are prominent. Cardiac Angiolipoma: A subtype of lipoma characterized by a prominent network of branching small blood vessels, sometimes containing microthrombi. In contrast, classic lipomas have sparse vascular components and lack such a vascular network. This subtype is also rare in the heart but must be considered when vascular components are prominent. Pericardial Fat Pad: This is a physiological accumulation of extrapericardial fat, not a true neoplasm. Unlike lipomas, it lacks a capsule, does not produce a mass effect, and does not compress cardiac structures. Microscopically, it consists solely of mature adipose tissue. Differentiation from a pericardial lipoma is primarily based on imaging and gross examination, which reveals a non-encapsulated, non-mass-like nature. Pericardial Fat Pad: This is a physiological accumulation of extrapericardial fat, not a true neoplasm. Unlike lipomas, it lacks a capsule, does not produce a mass effect, and does not compress cardiac structures. Microscopically, it consists solely of mature adipose tissue. Differentiation from a pericardial lipoma is primarily based on imaging and gross examination, which reveals a non-encapsulated, non-mass-like nature. Cardiac Myxoma: The most common primary cardiac tumor, cardiac myxomas have distinct histological features compared to lipomas. They are characterized by an abundant myxoid background, with scattered stellate or spindle-shaped cells, often arranged perivascularly, frequent hemorrhage, and hemosiderin deposition. Myxomas do not contain mature adipocytes. Immunohistochemically, myxoma cells typically express Calretinin and CD34, while lipoma cells express S-100. Cardiac Myxoma: The most common primary cardiac tumor, cardiac myxomas have distinct histological features compared to lipomas. They are characterized by an abundant myxoid background, with scattered stellate or spindle-shaped cells, often arranged perivascularly, frequent hemorrhage, and hemosiderin deposition. Myxomas do not contain mature adipocytes. Immunohistochemically, myxoma cells typically express Calretinin and CD34, while lipoma cells express S-100. Metastatic Tumors: Metastases, such as liposarcoma, renal cell carcinoma, hepatocellular carcinoma, or malignant melanoma, may resemble lipomas due to their lipid content or clear cytoplasm. Differentiation requires a thorough correlation with the clinical history (e.g., the presence of a primary malignancy) and immunohistochemical markers (e.g., RCC, HepPar-1, HMB45), which are not present in lipomas. Metastatic Tumors: Metastases, such as liposarcoma, renal cell carcinoma, hepatocellular carcinoma, or malignant melanoma, may resemble lipomas due to their lipid content or clear cytoplasm. Differentiation requires a thorough correlation with the clinical history (e.g., the presence of a primary malignancy) and immunohistochemical markers (e.g., RCC, HepPar-1, HMB45), which are not present in lipomas. Treatment and prognosis of cardiac lipomas require a tailored approach based on tumor location, size, and clinical presentation. Asymptomatic cases may not necessitate intervention, while surgical resection is indicated for arrhythmias, heart failure, hemodynamic obstruction, or when malignancy, such as liposarcoma, cannot be excluded [20]. Surgical strategy varies with tumor location: epicardial lipomas can often be resected via minimally invasive techniques, typically without the need for cardiopulmonary bypass. In contrast, tumors within the myocardium or cardiac chambers require cardiopulmonary bypass for clear visualization and complete excision [21]. Surgical resection is generally curative, offering a favorable prognosis and preventing recurrence. Although primary cardiac lipomas have been reported in the literature, case series with long-term follow-up data remain scarce. The clinical presentations, imaging characteristics, and pathological diagnoses of the three right atrial lipomas in this study align with previous reports [2, 3, 14]. Compared to the series by Amano et al. [2], the average age (57 years) and male predominance (2/3) in this cohort are consistent with the observed trend in middle-aged and elderly males. Tumor size in our cases (average 3 cm) falls within the commonly reported range of 2–5 cm [11, 12, 16]. Notably, this study provides long-term follow-up data ranging from 2 to 6 years post-operatively, with no recurrences observed. These findings further support the conclusion of Basso et al. [3] that cardiac lipomas have an excellent prognosis following complete resection. Thus, this case series not only confirms the typical characteristics of the disease but also offers robust clinical evidence of its benign biological behavior through long-term follow-up. Conclusion Primary cardiac lipoma, though exceedingly rare, carries significant clinical relevance. Some patients may remain asymptomatic or present with non-specific symptoms, which can lead to misdiagnosis as other cardiac tumors. Despite being benign, its critical location may result in severe complications such as arrhythmias, heart failure, and even sudden death. Multimodal imaging—comprising echocardiography, CT, and MRI—plays an essential role in preoperative assessment. For intracardiac masses originating in the atria that exhibit homogeneous hyperechoic (on ultrasound) or fat-signal (on MRI) characteristics, cardiac lipoma should be considered in the differential diagnosis, especially when atrial myxoma is initially suspected. Clinical management requires a multidisciplinary approach: radiologists identifying the characteristic fat components can help minimize misdiagnosis; surgeons should assess the relationship to valves and cardiac structures preoperatively and ensure complete resection; and pathologists should confirm the diagnosis by integrating histomorphology with immunohistochemistry, if necessary. Thus, improving preoperative imaging recognition and fostering interdisciplinary collaboration are crucial for enhancing diagnostic accuracy and optimizing patient outcomes.